Ensat stage I adrenal cortex carcinoma

Clinical trials for Ensat stage I adrenal cortex carcinoma explained in plain language.

Never miss a new study

Get alerted when new Ensat stage I adrenal cortex carcinoma trials appear

Sign up with your email to follow new studies for Ensat stage I adrenal cortex carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New trial tests chemo combo to stop rare adrenal Cancer's return

Disease control Recruiting now

This Phase 3 trial tests whether adding chemotherapy (cisplatin and etoposide) to the standard drug mitotane after surgery works better than mitotane alone for patients with adrenocortical carcinoma at high risk of recurrence. The study plans to enroll 240 adults with stage I-III…

Matched conditions: ENSAT STAGE I ADRENAL CORTEX CARCINOMA

Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

Ensat stage I adrenal cortex carcinoma

Get alerted when new Ensat stage I adrenal cortex carcinoma trials appear

New trial tests chemo combo to stop rare adrenal Cancer's return